Lumerax 60mg/360mg Tablet

Lumerax 60mg/360mg Tablet are a highly effective antimalarial medication designed for the treatment of uncomplicated malaria caused by Plasmodium falciparum. This higher-strength formulation is intended for adults, adolescents, and children with a higher body weight (usually above 35 kg), offering strong therapeutic coverage against chloroquine-resistant and multidrug-resistant malaria strains.

This fixed-dose combination is a part of Artemisinin-based Combination Therapy (ACT), the gold standard in malaria treatment as recommended by the World Health Organization (WHO). Each tablet contains:

• Artemether 60 mg – a fast-acting artemisinin derivative that rapidly kills malaria parasites during the early stages of their life cycle.

• Lumefantrine 360 mg – a longer-acting compound that eliminates the remaining parasites and prevents reinfection.

The dual-action mechanism not only provides quick symptom relief, such as fever, chills, and fatigue but also ensures complete parasite clearance when taken as prescribed. This strength is often used in weight-based malaria treatment protocols, especially in areas with high malaria transmission rates or where drug resistance is a concern.